Histological subtype and smoking status, but not gender, are associated with epidermal growth factor receptor mutations in non-smallcell lung cancer

Author：

Publisher： Spandidos Publications

ISSN： 2049-9469

Source： Molecular and Clinical Oncology, Vol.2, Iss.2, 2014-01, pp. : 252-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Surrogate endpoints for overall survival in advanced nonsmallcell lung cancer patients with mutations of the epidermal growth factor receptor gene

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 731-736

Spandidos Publications

Access to resources Recommend Favorite

Expression of epidermal growth factor receptor (EGFR) is frequent in inflammatory bowel disease (IBD)-associated intestinal cancer

By Svrcek Magali Cosnes Jacques Tiret Emmanuel Bennis Malika Parc Yann Fléjou Jean-François

Virchows Archiv, Vol. 450, Iss. 2, 2007-02 ,pp. : 243-244

Springer Publishing Company

Access to resources Recommend Favorite

Rechallenge with pemetrexed-based chemotherapy improves the survival of patients with advanced non-squamous non-smallcell lung cancer

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 953-959

Spandidos Publications

Access to resources Recommend Favorite

Misjudgement of gefitinib efficacy in patients with central non-smallcell lung cancer due to obstructive atelectasis caused by stereotactic radiotherapy

Molecular and Clinical Oncology, Vol. 2, Iss. 4, 2014-01 ,pp. : 535-538

Spandidos Publications

Access to resources Recommend Favorite

Prognostic value of peripheral and local forkhead box p3+ regulatory T cells in patients with non-smallcell lung cancer

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 685-694

Spandidos Publications

Access to resources Recommend Favorite